FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to the field of diagnosis of amyloidosis by staining histological samples, and can be used in pathological anatomy, cytology, clinical laboratory diagnostics and biology. Method of fluorescent identification of amyloid for the diagnosis of amyloidosis is based on the use of 2,7-(1-amino-4-sulfo-2-naphthylazo)fluorene for the staining of disodium salt preparations.
EFFECT: method does not require exceptionally high qualification of personnel, has a high degree of specificity and provides a low probability of false positive and false negative results due to the almost complete elimination of background staining of tissues.
1 cl, 2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR FLUORESCENCE HISTOLOGICAL DETECTION OF AMYLOID | 2015 |
|
RU2611408C1 |
METHOD FOR SIMULATING EXPERIMENTAL AMYLOID DISEASE IN ANIMALS | 2014 |
|
RU2572721C1 |
METHOD FOR PROPHYLAXIS AND TREATMENT OF SYSTEMIC AMYLOIDOSIS AND NEPHROPATHIC FORM THEREOF IN EXPERIMENTAL ANIMALS | 2004 |
|
RU2270672C1 |
METHOD OF ANALYZING INITIAL AND SENILE AMYLOIDOSE | 0 |
|
SU1467431A1 |
METHOD FOR MODELING EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2004 |
|
RU2269825C1 |
METHOD OF SIMULATING AMYLOIDOSIS IN ANIMALS | 2008 |
|
RU2373581C1 |
METHOD FOR SIMULATING GENERALISED AMYLOIDOSIS IN ANIMALS | 2013 |
|
RU2536556C2 |
METHOD FOR SIMULATION OF EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2010 |
|
RU2446482C1 |
METHOD OF DETECTING MAST CELLS ON HISTOLOGICAL PREPARATIONS OF THE HUMAN HEART | 2022 |
|
RU2798117C1 |
EXOGENIC-INDUCED ANIMAL MODEL OF ALZHEIMER DISEASE | 2012 |
|
RU2532525C2 |
Authors
Dates
2018-11-30—Published
2017-11-30—Filed